Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.

Shu-Fen LiaoJill KoshiolYi-Hsiang Huang Sarah S JacksonYu-Han HuangChi ChanClaire HuangPo-Chun LiuYen-Ju ChenRebecca J HsiehChing-Po HuangSheng-Nan LuChien-Jen ChenChen-Yang ShenMei-Hsuan Lee

Published in: Hepatology (Baltimore, Md.) (2021)

The nationwide study revealed that postdiagnosis aspirin use was associated with improved BTC-specific mortality of various subtypes. The findings suggest that additional randomized trials are required to investigate aspirin's efficacy in BTC.

Keyphrases

cardiovascular events
low dose
coronary artery disease
antiplatelet therapy
cardiovascular disease
papillary thyroid
risk factors
anti inflammatory drugs
squamous cell
single cell
squamous cell carcinoma
cross sectional
type diabetes
atrial fibrillation